Showing results (1-10 of 291) with videos related to
Sort By:
Pageof 30
Annals of Epidemiology|November 14, 1997
Ischemic heart disease and alcohol-related causes of death: a view of the French paradoxB Balkau, F Eschwege, E EschwegeBulletin Du Cancer|July 9, 2004
[Cyclooxygenase 2 inhibitors and urologic and gynaecologic cancers]Pascal EschwegeBulletin Du Cancer|May 19, 2005
[Cyclooxygenase 2 inhibitors and urologic and gynaecologic cancers]Pascal EschwegeDiabete & Metabolisme|October 1, 1995
Risk factors and their identification. Third Part: ExamplesB Balkau, E EschwegeBulletin Du Cancer|January 1, 1981
[Combination of radiotherapy and chemotherapy in the treatment of upper respiratory and digestive tract carcinomas (author's transl)]Y Cachin, F EschwegeJournal of Perinatal Medicine|January 1, 1976
Estrogens, lactation and oral glucose tolerance test in the early puerperiumD Job, E EschwegeDiabete & Metabolisme|June 1, 1995
Risk factors and their identification second part: study designs for identification of risk factorsB Balkau, E EschwegeDiabete & Metabolisme|July 1, 1987
Diabetes, hyperglycaemia, hyperinsulinaemia and atherosclerosis: epidemiological dataA Fontbonne, E EschwegeDiabete & Metabolisme|February 1, 1995
Risk factors and their identification. First Part: What is a risk factor?B Balkau, E EschwegeThe Journal of Urology|October 9, 2003
Cyclooxygenase-2 inhibitor NS398 enhances antitumor effect of irradiation on hormone refractory human prostate carcinoma cellsBixiu Wen, Eric Deutsch, Pascal Eschwege, et al.Pageof 30